Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
      H.R. No. 1298       R E S O L U T I O N          WHEREAS, The observance of Premenstrual Dysphoric Disorder   Awareness Day on November 8, 2025, provides a fitting opportunity   to rally support for women living with the condition; and          WHEREAS, Premenstrual Dysphoric Disorder is a cyclical   hormone-based mood disorder with mental, emotional, and physical   symptoms that arise each month during the premenstrual phase of the   menstrual cycle; PMDD presents itself one to two weeks before an   individual begins menstruating, and symptoms may include mood   swings, irritability, depression, difficulty focusing, sensitivity   to rejection, changes in appetite, and muscle pain; typically, the   disorder is diagnosed by tracking symptoms on a daily basis for two   or more menstrual cycles; and          WHEREAS, PMDD symptoms can significantly disrupt daily life   and exacerbate mental health issues; many women with PMDD report   experiencing suicidal thoughts during symptomatic times, and the   disorder has led to higher rates of attempted suicide and   self-harm; individuals experiencing the disorder may suffer from   frequently missed workdays, reduced productivity, strained   relationships, career disruption, educational setbacks, and   financial stress from ongoing health care needs; and          WHEREAS, An estimated 115 million women around the globe are   affected by PMDD; like most menstrual disorders, PMDD diagnoses are   very rare and research on the disorder is extremely limited;   although PMDD affects up to five percent of women of childbearing   age in the United States, over half of people with the disorder   experience misdiagnoses or dismissals from providers; due to stigma   surrounding mental health and menstruation, people with PMDD often   suffer in silence and delay care, which increases the risk of   negative outcomes; currently, there are no cures for the disorder,   and it is most commonly managed by the prescription of oral   contraceptives and antidepressant medications as well as through   lifestyle choices; and          WHEREAS, PMDD is a serious and life-changing health issue,   and the observance of Premenstrual Dysphoric Disorder Awareness Day   serves as a means of educating the public and promoting further   research on menstrual and hormone-related mood disorders; now,   therefore, be it          RESOLVED, That the House of Representatives of the 89th Texas   Legislature hereby recognize November 8, 2025, as Premenstrual   Dysphoric Disorder Awareness Day and encourage all Texans to learn   more about PMDD.     Howard     ______________________________   Speaker of the House                 I certify that H.R. No. 1298 was adopted by the House on May   29, 2025, by a non-record vote.     ______________________________   Chief Clerk of the House